Updated report on tools to measure outcomes of clinical trials in fragile X syndrome

OBJECTIVE: Fragile X syndrome (FXS) has been the neurodevelopmental disorder with the most active translation of preclinical breakthroughs into clinical trials. This process has led to a critical assessment of outcome measures, which resulted in a comprehensive review published in 2013. Nevertheless...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Neurodev Disord
Main Authors: Budimirovic, Dejan B., Berry-Kravis, Elizabeth, Erickson, Craig A., Hall, Scott S., Hessl, David, Reiss, Allan L., King, Margaret K., Abbeduto, Leonard, Kaufmann, Walter E.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5467057/
https://ncbi.nlm.nih.gov/pubmed/28616097
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s11689-017-9193-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados